Human Molecular Genetics, Vol 7, 265-272, Copyright © 1998 by Oxford University Press
A Jalanko, K Tenhunen, CE McKinney, ME LaMarca, J Rapola, T Autti, R Joensuu, T Manninen, I Sipila, S Ikonen, P Riekkinen Jr, EI Ginns and L Peltonen
Aspartyglucosaminuria (AGU) is a lysosomal storage disease with autosomal
recessive inheritance that is caused by deficient activity of
aspartylglucosaminidase (AGA), a lysosomal enzyme belonging to the newly
described enzyme family of N-terminal hydrolases. An AGU mouse model was
generated by targeted disruption of the AGA gene designed to mimic closely
one human disease mutation. These homozygous mutant mice have no detectable
AGA activity and excrete aspartylglucosamine in their urine. Analogously to
the human disease, the affected homozygous animals showed storage in
lysosomes in all analyzed tissues, including the brain, liver, kidney and
skin, and lysosomal storage was already detected in fetuses at 19 days
gestation. Electron microscopic studies of brain tissue samples
demonstrated lysosomal storage vacuoles in the neurons and glia of the
neocortical and cortical regions. Magnetic resonance images (MRI)
facilitating monitoring of the brains of living animals indicated cerebral
atrophy and hypointensity of the deep gray matter structures of
brain-findings similar to those observed in human patients. AGU mice are
fertile, and up to 11 months of age their movement and behavior do not
differ from their age-matched littermates. However, in the Morris water
maze test, a slow worsening of performance could be seen with age. The
phenotype mimics well AGU in humans, the patients characteristically
showing only slowly progressive mental retardation and relatively mild
skeletal abnormalities.
ARTICLES
Mice with an aspartylglucosaminuria mutation similar to humans replicate the pathophysiology in patients
National Public Health Institute, Department of Human Molecular Genetics, Mannerheimintie 166, 00300 Helsinki, Finland.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
D.-A. N. W. Persaud-Sawin, A. VanDongen, and R.-M. N. Boustany Motifs within the CLN3 protein: modulation of cell growth rates and apoptosis Hum. Mol. Genet., September 1, 2002; 11(18): 2129 - 2142. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Putaala, R. Soininen, P. Kilpelainen, J. Wartiovaara, and K. Tryggvason The murine nephrin gene is specifically expressed in kidney, brain and pancreas: inactivation of the gene leads to massive proteinuria and neonatal death Hum. Mol. Genet., January 1, 2001; 10(1): 1 - 8. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Peltonen, A. Jalanko, and T. Varilo Molecular genetics of the Finnishdisease heritage Hum. Mol. Genet., September 1, 1999; 8(10): 1913 - 1923. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kyttala, O. Heinonen, L. Peltonen, and A. Jalanko Expression and Endocytosis of Lysosomal Aspartylglucosaminidase in Mouse Primary Neurons J. Neurosci., October 1, 1998; 18(19): 7750 - 7756. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Johnson, G. P. Cofer, S. L. Gewalt, and L. W. Hedlund Morphologic Phenotyping with MR Microscopy: The Visible Mouse Radiology, March 1, 2002; 222(3): 789 - 793. [Abstract] [Full Text] [PDF] |
||||


